Literature DB >> 23066029

Inhibition of DNA damage-induced apoptosis through Cdc7-mediated stabilization of Tob.

Toru Suzuki1, Junko Tsuzuku, Akiyo Hayashi, Yasushi Shiomi, Hiroko Iwanari, Yasuhiro Mochizuki, Takao Hamakubo, Tatsuhiko Kodama, Hideo Nishitani, Hisao Masai, Tadashi Yamamoto.   

Abstract

BACKGROUND: Preventing unnecessary cell death is essential for DNA-damaged cells to carry out the DNA repair process.
RESULTS: Cdc7 inhibits the Cul4-DDB1(Cdt2)-dependent Tob degradation.
CONCLUSION: Cdc7 enables mild DNA-damaged cells to keep their viability by competing with the Tob degradation system. SIGNIFICANCE: Cells deal with moderate DNA damage not only by cessation of the cell cycle but also through direct mediated pro-survival signaling. Cells respond to DNA damage by activating alternate signaling pathways that induce proliferation arrest or apoptosis. The correct balance between these two pathways is important for maintaining genomic integrity and preventing unnecessary cell death. The mechanism by which DNA-damaged cells escape from apoptosis during DNA repair is poorly understood. We show that the DNA replication-initiating kinase Cdc7 actively prevents unnecessary death in DNA-damaged cells. In response to mild DNA damage, Tob levels increase through both a transcriptional mechanism and protein stabilization, resulting in inhibition of pro-apoptotic signaling. Cells lacking Cdc7 expression undergo apoptosis after mild DNA damage, where Cul4-DDB1(Cdt2) induces Tob ubiquitination and subsequent degradation. Cdc7 phosphorylates and interacts with Tob to inhibit the Cul4-DDB1(Cdt2)-dependent Tob degradation. Thus, Cdc7 defines an essential pro-survival signaling pathway by contributing to stabilization of Tob, thereby the viability of DNA-damaged cells being maintained.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23066029      PMCID: PMC3504742          DOI: 10.1074/jbc.M112.353805

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  33 in total

Review 1.  The DNA damage response: putting checkpoints in perspective.

Authors:  B B Zhou; S J Elledge
Journal:  Nature       Date:  2000-11-23       Impact factor: 49.962

Review 2.  Cell cycle checkpoint signaling through the ATM and ATR kinases.

Authors:  R T Abraham
Journal:  Genes Dev       Date:  2001-09-01       Impact factor: 11.361

3.  The generation of monoclonal antibodies against human peroxisome proliferator-activated receptors (PPARs).

Authors:  Toshiya Tanaka; Tetsu Takeno; Yuichiro Watanabe; Yasutoshi Uchiyama; Takeshi Murakami; Hisahiko Yamashita; Akifumi Suzuki; Rie Aoi; Hiroko Iwanari; Shu-Ying Jiang; Makoto Naito; Keisuke Tachibana; Takefumi Doi; Andrew I Shulman; David J Mangelsdorf; Raphael Reiter; Johan Auwerx; Takao Hamakubo; Tatsuhiko Kodama
Journal:  J Atheroscler Thromb       Date:  2002       Impact factor: 4.928

4.  Lack of RB protein correlates with increased sensitivity to UV-radiation-induced apoptosis in human breast cancer cells.

Authors:  C A Carlson; S P Ethier
Journal:  Radiat Res       Date:  2000-11       Impact factor: 2.841

5.  Lack of functional pRb results in attenuated recovery of mRNA synthesis and increased apoptosis following UV radiation in human breast cancer cells.

Authors:  Christine A Billecke; Mats E Ljungman; Bruce C McKay; Alnawaz Rehemtulla; Neelam Taneja; Stephen P Ethier
Journal:  Oncogene       Date:  2002-07-04       Impact factor: 9.867

6.  An ATR- and Cdc7-dependent DNA damage checkpoint that inhibits initiation of DNA replication.

Authors:  Vincenzo Costanzo; David Shechter; Patrick J Lupardus; Karlene A Cimprich; Max Gottesman; Jean Gautier
Journal:  Mol Cell       Date:  2003-01       Impact factor: 17.970

Review 7.  Cell-cycle control in the face of damage--a matter of life or death.

Authors:  Paul R Clarke; Lindsey A Allan
Journal:  Trends Cell Biol       Date:  2009-01-23       Impact factor: 20.808

8.  Arrest of G(1)-S progression by the p53-inducible gene PC3 is Rb dependent and relies on the inhibition of cyclin D1 transcription.

Authors:  D Guardavaccaro; G Corrente; F Covone; L Micheli; I D'Agnano; G Starace; M Caruso; F Tirone
Journal:  Mol Cell Biol       Date:  2000-03       Impact factor: 4.272

9.  Mice lacking a transcriptional corepressor Tob are predisposed to cancer.

Authors:  Yutaka Yoshida; Takahisa Nakamura; Masato Komoda; Hitoshi Satoh; Toru Suzuki; Junko K Tsuzuku; Takashi Miyasaka; Eri H Yoshida; Hisashi Umemori; Reiko K Kunisaki; Kenzaburo Tani; Shunsuke Ishii; Shigeo Mori; Masami Suganuma; Tetsuo Noda; Tadashi Yamamoto
Journal:  Genes Dev       Date:  2003-05-15       Impact factor: 11.361

10.  Phosphorylation of three regulatory serines of Tob by Erk1 and Erk2 is required for Ras-mediated cell proliferation and transformation.

Authors:  Toru Suzuki; Junko K-Tsuzuku; Rieko Ajima; Takahisa Nakamura; Yutaka Yoshida; Tadashi Yamamoto
Journal:  Genes Dev       Date:  2002-06-01       Impact factor: 11.361

View more
  12 in total

1.  Cdc7-dependent and -independent phosphorylation of Claspin in the induction of the DNA replication checkpoint.

Authors:  Michael D Rainey; Brendan Harhen; Guan-Nan Wang; Paul V Murphy; Corrado Santocanale
Journal:  Cell Cycle       Date:  2013-04-17       Impact factor: 4.534

2.  Acquisition of estrogen independence induces TOB1-related mechanisms supporting breast cancer cell proliferation.

Authors:  Y-W Zhang; R E Nasto; R Varghese; S A Jablonski; I G Serebriiskii; R Surana; V S Calvert; I Bebu; J Murray; L Jin; M Johnson; R Riggins; H Ressom; E Petricoin; R Clarke; E A Golemis; L M Weiner
Journal:  Oncogene       Date:  2015-07-13       Impact factor: 9.867

3.  MiR-200a with CDC7 as a direct target declines cell viability and promotes cell apoptosis in Wilm's tumor via Wnt/β-catenin signaling pathway.

Authors:  Xiu-Ling Liang; Yu-Long Wang; Pei-Rong Wang
Journal:  Mol Cell Biochem       Date:  2021-02-18       Impact factor: 3.396

Review 4.  Transducer of ERBB2.1 (TOB1) as a Tumor Suppressor: A Mechanistic Perspective.

Authors:  Hun Seok Lee; Juthika Kundu; Ryong Nam Kim; Young Kee Shin
Journal:  Int J Mol Sci       Date:  2015-12-15       Impact factor: 5.923

5.  A high through-put screen for small molecules modulating MCM2 phosphorylation identifies Ryuvidine as an inducer of the DNA damage response.

Authors:  Jennifer FitzGerald; Laura S Murillo; Gemma O'Brien; Enda O'Connell; Aisling O'Connor; Kevin Wu; Guan-Nan Wang; Michael D Rainey; Alessandro Natoni; Sandra Healy; Michael O'Dwyer; Corrado Santocanale
Journal:  PLoS One       Date:  2014-06-05       Impact factor: 3.240

6.  The stress phenotype makes cancer cells addicted to CDT2, a substrate receptor of the CRL4 ubiquitin ligase.

Authors:  Martina Olivero; Daniela Dettori; Sabrina Arena; Davide Zecchin; Erica Lantelme; Maria Flavia Di Renzo
Journal:  Oncotarget       Date:  2014-08-15

Review 7.  Cullin family proteins and tumorigenesis: genetic association and molecular mechanisms.

Authors:  Zhi Chen; Jie Sui; Fan Zhang; Caiguo Zhang
Journal:  J Cancer       Date:  2015-01-16       Impact factor: 4.207

8.  Structural basis for inhibition of the Tob-CNOT7 interaction by a fragment screening approach.

Authors:  Yuwei Bai; Shinya Tashiro; Satoru Nagatoishi; Toru Suzuki; Dongke Yan; Ruihua Liu; Kouhei Tsumoto; Mark Bartlam; Tadashi Yamamoto
Journal:  Protein Cell       Date:  2015-12       Impact factor: 14.870

Review 9.  The emerging role for Cullin 4 family of E3 ligases in tumorigenesis.

Authors:  Ji Cheng; Jianping Guo; Brian J North; Kaixiong Tao; Pengbo Zhou; Wenyi Wei
Journal:  Biochim Biophys Acta Rev Cancer       Date:  2018-12-30       Impact factor: 10.680

10.  MicroRNA-29a regulates the benzo[a]pyrene dihydrodiol epoxide-induced DNA damage response through Cdc7 kinase in lung cancer cells.

Authors:  L R Barkley; C Santocanale
Journal:  Oncogenesis       Date:  2013-07-22       Impact factor: 7.485

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.